Complete in vivo reversal of the multidrug resistance phenotype by jet-injection of anti-MDR1 short hairpin RNA-encoding plasmid DNA. (Q52923257)

9 May 2018

title

Complete in vivo reversal of the multidrug resistance phenotype by jet-injection of anti-MDR1 short hairpin RNA-encoding plasmid DNA. (English)

1 reference

9 May 2018

main subject

multiple drug resistance

1 reference

1 reference

Ulrike Stein

1

1 reference

9 May 2018

Wolfgang Walther

2

1 reference

9 May 2018

Alexandra Stege

3

1 reference

9 May 2018

Alexander Kaszubiak

4

1 reference

9 May 2018

Iduna Fichtner

5

1 reference

9 May 2018

Hermann Lage

6

1 reference

9 May 2018

publication date

18 September 2007

1 reference

9 May 2018

published in

Molecular Therapy

1 reference

9 May 2018

volume

16

1 reference

9 May 2018

issue

1

1 reference

9 May 2018

page(s)

178-186

1 reference

9 May 2018

ABC-transporters: implications on drug resistance from microorganisms to human cancers

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Targeting multidrug resistance in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

MDR1/P-glycoprotein in haematological neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

MDR1 gene expression in solid tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Potential applications of RNA interference technology in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

MDR1/P-glycoprotein (ABCB1) as target for RNA interference-mediated reversal of multidrug resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

1 reference

7 January 2021

Progress and prospects: naked DNA gene transfer and therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Gene therapy progress and prospects: nonviral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Gene transfer by jet injection into differentiated tissues of living animals and in organ culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Nonviral in vivo gene delivery into tumors using a novel low volume jet-injection technology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Low-volume jet injection for efficient nonviral in vivo gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Nonviral jet-injection gene transfer for efficient in vivo cytosine deaminase suicide gene therapy of colon carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Uptake, biodistribution, and time course of naked plasmid DNA trafficking after intratumoral in vivo jet injection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Complete reversal of ABCG2-depending atypical multidrug resistance by RNA interference in human carcinoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Sequence-specific suppression of mdr1a/1b expression in mice via RNA interference

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Expression of multidrug resistance genes MVP, MDR1, and MRP1 determined sequentially before, during, and after hyperthermic isolated limb perfusion of soft tissue sarcoma and melanoma patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300304

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300304

1 reference

9 May 2018

PubMed ID

17878902

1 reference

9 May 2018